Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 3
2023 1
2024 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Circulating tumor DNA and Response Evaluation Criteria In Solid Tumors: ctDNA-RECIST proof-of-concept in HER2-positive metastatic breast cancer.
Fabi A, Giordani E, Ricciardi E, Arpino G, Allegretti M, Ferretti G, Omarini C, Zambelli A, Mandoj C, Botticelli A, Bria E, Gori S, Carbognin L, Paris I, Scambia G, Cognetti F, Giannarelli D, Giacomini P. Fabi A, et al. Among authors: ricciardi e. J Exp Clin Cancer Res. 2026 Jan 20;45(1):67. doi: 10.1186/s13046-025-03605-2. J Exp Clin Cancer Res. 2026. PMID: 41559726 Free PMC article.
A first-in-class non-cytotoxic nanocarrier based on a recombinant human ferritin boosts targeted therapy, chemotherapy and immunotherapy.
Tisci G, Rajsiglova L, Bibbo S, Ziccheddu G, Ricciardi E, Falvo E, De Laurenzi V, Sala G, Capone E, Colotti G, Arcovito A, Giacon N, Makovický P, Sushytskyi L, Lukac P, Vannucci L, Giacomini P, Ceci P. Tisci G, et al. Among authors: ricciardi e. Int J Biol Macromol. 2025 May;309(Pt 1):142843. doi: 10.1016/j.ijbiomac.2025.142843. Epub 2025 Apr 3. Int J Biol Macromol. 2025. PMID: 40187454 Free article.
Monitoring changing patterns in HER2 addiction by liquid biopsy in advanced breast cancer patients.
Giordani E, Allegretti M, Sinibaldi A, Michelotti F, Ferretti G, Ricciardi E, Ziccheddu G, Valenti F, Di Martino S, Ercolani C, Giannarelli D, Arpino G, Gori S, Omarini C, Zambelli A, Bria E, Paris I, Buglioni S, Giacomini P, Fabi A. Giordani E, et al. Among authors: ricciardi e. J Exp Clin Cancer Res. 2024 Jun 29;43(1):182. doi: 10.1186/s13046-024-03105-9. J Exp Clin Cancer Res. 2024. PMID: 38951853 Free PMC article.
Metastatic Melanoma: Liquid Biopsy as a New Precision Medicine Approach.
Ricciardi E, Giordani E, Ziccheddu G, Falcone I, Giacomini P, Fanciulli M, Russillo M, Cerro M, Ciliberto G, Morrone A, Guerrisi A, Valenti F. Ricciardi E, et al. Int J Mol Sci. 2023 Feb 16;24(4):4014. doi: 10.3390/ijms24044014. Int J Mol Sci. 2023. PMID: 36835424 Free PMC article. Review.
Laboratory tests during direct oral anticoagulant treatment? No.
Di Minno G, Ricciardi E, Scalera A. Di Minno G, et al. Among authors: ricciardi e. Intern Emerg Med. 2013 Aug;8(5):367-70. doi: 10.1007/s11739-013-0948-4. Epub 2013 May 21. Intern Emerg Med. 2013. PMID: 23686689 No abstract available.